Immuron Statistics
NASDAQ: IMRNHealthcareBiotechnologyUSD
1.11+0.02 (+1.83%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Immuron by the numbers
Immuron has a market capitalization of $9.0 million based on 8.07M shares outstanding. With trailing EPS of $-0.34, Immuron is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 7.2% below its 50-day average and 10.1% above its 200-day average.
Average daily trading volume is 2.06M shares, or about $2.3 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
IMRN valuation vs. peer median
| Metric | IMRN | Peer median | Difference |
|---|---|---|---|
| Market cap | $8.96M | $8.73M | +3% |
| Avg. volume | 2.06M | 756.84K | +173% |
Peer median across 8 companies: JAGX, MTVA, CALC, ENSC, MBRX, AZTR, CNSP, FBLG.
Valuation
- Market cap
- $8.96M
- EPS (TTM)
- $-0.34
- Shares outstanding
- 8.07M
Price and trading
- Previous close
- 1.09
- Open
- 1.10
- Day range
- 1.09 – 1.17
- 52-week range
- 0.677 – 2.39
- Beta
- —
- Volume
- 34.19K
- Average volume
- 2.06M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 28, 2025
Additional statistics
- Market Cap
- 8.96M
- Forward Pe
- -111.00
- Eps
- -0.34
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 2.39
- Week52 Low
- 0.68
- Avg Volume
- 2.06M
- Shares Outstanding
- 8.07M
- Ma50
- 1.20
- Ma200
- 1.01
- Earnings Date
- Aug 28, 2025
- Pct From52w High
- -53.56%
- Pct From52w Low
- 63.96%